Stryker has entered into a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers LLC, a New York-based investment firm specializing in neuromusculoskeletal technologies.

The newly formed company, VB Spine LLC, will acquire the business, while Stryker also plans to divest its related international operations.

Following the transaction, VB Spine will become a strategic partner to Stryker, gaining exclusive access to Mako Spine and Copilot technologies for use with its spinal implants in surgical procedures.
“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company,” said Kevin A. Lobo, chair and CEO of Stryker. “With dedicated resources and a focused strategy, the business will be well positioned to succeed as part of Viscogliosi Brothers.”

The agreement also includes a binding offer for Viscogliosi Brothers to acquire Stryker’s spinal implants business in France, pending consultations with employees and representatives. Additional international sales are expected, subject to regulatory approvals.

The transaction is anticipated to close in the first half of 2025, pending customary closing conditions. Until then, Stryker’s spinal implants business and VB Spine will continue to operate independently.

Barings LLC, a global asset management firm, is providing financial backing for the acquisition.

Operating Room Homepage